JAMA Psychiatry : Serial Ketamine Infusions as an Adjunctive Therapy to Inpatient Care for Depression
JAMA Network
00:00
Secondary Outcomes: Cost, Quality of Life, and Safety
John Torous asks about other endpoints; McLoughlin says no differences in cost‑effectiveness, quality of life, cognition, or adverse events.
Play episode from 16:06
Transcript
